Literature DB >> 14410698

Natural history and pathogenesis of renal ablation hypertension.

S KOLETSKY, A M GOODSITT.   

Abstract

Entities:  

Keywords:  HYPERTENSION/experimental; NEPHRECTOMY/experimental

Mesh:

Year:  1960        PMID: 14410698

Source DB:  PubMed          Journal:  Arch Pathol        ISSN: 0363-0153


× No keyword cloud information.
  8 in total

1.  Experimental pyelonephritis. The effect of chronic infection on the blood pressure in the rat.

Authors:  R H HEPTINSTALL
Journal:  Br J Exp Pathol       Date:  1962-06

2.  N-desulfated/acetylated heparin ameliorates the progression of renal disease in rats with subtotal renal ablation.

Authors:  M L Purkerson; D M Tollefsen; S Klahr
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

3.  [The behavior of the myocardium in experimental supravalvular aortic stenosis. Autoradiographic and electron microscopic studies of rat heart].

Authors:  G Wegner; E Mölbert
Journal:  Virchows Arch Pathol Anat Physiol Klin Med       Date:  1966-04-13

4.  The cellular pathology of experimental hypertension. 3. Glomerular alterations.

Authors:  Z Ben-Ishay; D Spiro; J Wiener
Journal:  Am J Pathol       Date:  1966-10       Impact factor: 4.307

5.  A rat model of progressive chronic renal failure produced by microembolism.

Authors:  M Kimura; T Suzuki; A Hishida
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

6.  Inhibition of thromboxane synthesis ameliorates the progressive kidney disease of rats with subtotal renal ablation.

Authors:  M L Purkerson; J H Joist; J Yates; A Valdes; A Morrison; S Klahr
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

7.  Glomerular epithelial cell function and pathology following extreme ablation of renal mass.

Authors:  M M Schwartz; A K Bidani; E J Lewis
Journal:  Am J Pathol       Date:  1987-02       Impact factor: 4.307

8.  Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass.

Authors:  S Anderson; T W Meyer; H G Rennke; B M Brenner
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.